Clinical Trial Update: Erythropoietin in Methanol Associated Optic Neuropathy: A Phase-2 Clinical Trial (EPO-MAON Study) [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating erythropoietin for methanol-associated optic neuropathy is reported, with status unspecified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Optic Nerve Diseases

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Optic Nerve Diseases | Phase 3 | Status: UNKNOWN